对神经保护的研究必须继续……但要采用不同的方法。 - Suppr

Suppr

超能文献

Research into neuroprotection must continue ... But with a different approach.

作者信息

Hussain Muhammad S, Shuaib Ashfaq

机构信息

Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada.

出版信息

Stroke. 2008 Feb;39(2):521-2. doi: 10.1161/STROKEAHA.107.494781. Epub 2008 Jan 17.

DOI:10.1161/STROKEAHA.107.494781

PMID:18202310

Abstract

摘要

相似文献

Research into neuroprotection must continue ... But with a different approach.

Stroke. 2008 Feb;39(2):521-2. doi: 10.1161/STROKEAHA.107.494781. Epub 2008 Jan 17.

Neuroprotection does not work!

Stroke. 2008 Feb;39(2):523-4. doi: 10.1161/STROKEAHA.107.494799. Epub 2008 Jan 17.

Neuroprotection: still achievable in humans.

Stroke. 2008 Feb;39(2):525. doi: 10.1161/STROKEAHA.107.494807. Epub 2008 Jan 17.

[The intervention treatment of neuroprotection for ischemic stroke].

Sheng Li Ke Xue Jin Zhan. 2012 Aug;43(4):279-82.

Acute stroke therapy: translating preclinical neuroprotection to therapeutic reality.

Curr Opin Investig Drugs. 2000 Dec;1(4):452-63.

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

Lancet. 2000 Jun 3;355(9219):1925-6. doi: 10.1016/S0140-6736(00)02318-7.

Novel approaches to neuroprotection trials in acute ischemic stroke.

Stroke. 2013 Oct;44(10):2942-50. doi: 10.1161/STROKEAHA.113.000731. Epub 2013 Sep 10.

Neuroprotection in ischemic stroke: what does the future hold?

Expert Rev Neurother. 2015 Mar;15(3):227-9. doi: 10.1586/14737175.2015.1014806.

Is it time to definitely abandon neuroprotection in acute ischemic stroke?

Stroke. 2008 Jun;39(6):1659-60. doi: 10.1161/STROKEAHA.107.505024. Epub 2008 Mar 27.

[Past, present and future of neuroprotection].

Cas Lek Cesk. 2010;149(12):586-90.

引用本文的文献

Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers.

BMJ Open Sci. 2020 Feb 24;4(1):e100041. doi: 10.1136/bmjos-2019-100041. eCollection 2020.

-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway.

Int J Mol Sci. 2019 Sep 29;20(19):4845. doi: 10.3390/ijms20194845.

Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke.

Curr Neuropharmacol. 2017;15(6):892-905. doi: 10.2174/1570159X15666170112170226.

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.

Transl Stroke Res. 2016 Feb;7(1):54-69. doi: 10.1007/s12975-015-0440-8. Epub 2015 Dec 26.

Molecular pathophysiology of cerebral edema.

J Cereb Blood Flow Metab. 2016 Mar;36(3):513-38. doi: 10.1177/0271678X15617172. Epub 2015 Nov 16.

Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.

Mol Neurobiol. 2016 Jan;53(1):320-330. doi: 10.1007/s12035-014-8984-2. Epub 2014 Nov 29.

Lipoxygenase: an emerging target for stroke therapy.

CNS Neurol Disord Drug Targets. 2013 Mar;12(2):191-9. doi: 10.2174/18715273112119990053.

The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy.

Med Sci Monit Basic Res. 2013 Jan 28;19:37-45. doi: 10.12659/msmbr.883750.

Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke.

Neurosci Lett. 2011 Apr 4;492(3):134-8. doi: 10.1016/j.neulet.2011.01.073. Epub 2011 Feb 4.

Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Ann N Y Acad Sci. 2010 Jun;1198:260-70. doi: 10.1111/j.1749-6632.2010.05434.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Research into neuroprotection must continue ... But with a different approach.

Stroke. 2008 Feb;39(2):521-2. doi: 10.1161/STROKEAHA.107.494781. Epub 2008 Jan 17.

Neuroprotection does not work!

Stroke. 2008 Feb;39(2):523-4. doi: 10.1161/STROKEAHA.107.494799. Epub 2008 Jan 17.

Neuroprotection: still achievable in humans.

Stroke. 2008 Feb;39(2):525. doi: 10.1161/STROKEAHA.107.494807. Epub 2008 Jan 17.

[The intervention treatment of neuroprotection for ischemic stroke].

Sheng Li Ke Xue Jin Zhan. 2012 Aug;43(4):279-82.

Acute stroke therapy: translating preclinical neuroprotection to therapeutic reality.

Curr Opin Investig Drugs. 2000 Dec;1(4):452-63.

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

Lancet. 2000 Jun 3;355(9219):1925-6. doi: 10.1016/S0140-6736(00)02318-7.

Novel approaches to neuroprotection trials in acute ischemic stroke.

Stroke. 2013 Oct;44(10):2942-50. doi: 10.1161/STROKEAHA.113.000731. Epub 2013 Sep 10.

Neuroprotection in ischemic stroke: what does the future hold?

Expert Rev Neurother. 2015 Mar;15(3):227-9. doi: 10.1586/14737175.2015.1014806.

Is it time to definitely abandon neuroprotection in acute ischemic stroke?

Stroke. 2008 Jun;39(6):1659-60. doi: 10.1161/STROKEAHA.107.505024. Epub 2008 Mar 27.

[Past, present and future of neuroprotection].

Cas Lek Cesk. 2010;149(12):586-90.

引用本文的文献

Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers.

BMJ Open Sci. 2020 Feb 24;4(1):e100041. doi: 10.1136/bmjos-2019-100041. eCollection 2020.

-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway.

Int J Mol Sci. 2019 Sep 29;20(19):4845. doi: 10.3390/ijms20194845.

Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke.

Curr Neuropharmacol. 2017;15(6):892-905. doi: 10.2174/1570159X15666170112170226.

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.

Transl Stroke Res. 2016 Feb;7(1):54-69. doi: 10.1007/s12975-015-0440-8. Epub 2015 Dec 26.

Molecular pathophysiology of cerebral edema.

J Cereb Blood Flow Metab. 2016 Mar;36(3):513-38. doi: 10.1177/0271678X15617172. Epub 2015 Nov 16.

Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.

Mol Neurobiol. 2016 Jan;53(1):320-330. doi: 10.1007/s12035-014-8984-2. Epub 2014 Nov 29.

Lipoxygenase: an emerging target for stroke therapy.

CNS Neurol Disord Drug Targets. 2013 Mar;12(2):191-9. doi: 10.2174/18715273112119990053.

The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy.

Med Sci Monit Basic Res. 2013 Jan 28;19:37-45. doi: 10.12659/msmbr.883750.

Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for stroke.

Neurosci Lett. 2011 Apr 4;492(3):134-8. doi: 10.1016/j.neulet.2011.01.073. Epub 2011 Feb 4.

Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Ann N Y Acad Sci. 2010 Jun;1198:260-70. doi: 10.1111/j.1749-6632.2010.05434.x.